Ph.D EVP and Chief Business Officer
Gritstone
Matthew Hawryluk
Matthew Hawryluk, Ph.D. has served as the Executive Vice President and Chief Business Officer at Gritstone since October 2015. Prior to Gritstone, from April 2011 to October 2015, Dr. Hawryluk held positions of increasing responsibility at Foundation Medicine, a public molecular diagnostics company, most recently serving as Vice President, Corporate and Business Development.
Previously, Dr. Hawryluk held roles in Business Development, Marketing and Product Management across multiple divisions of Thermo Fisher Scientific, Inc. In May 2022, Dr. Hawryluk was named a 2022 Emerging Pharma Leader by Pharmaceutical Executive. Dr. Hawryluk received a B.S. from the University of Notre Dame, a Ph.D. in Cell Biology and Protein Biochemistry from the University of Pittsburgh School of Medicine and an M.B.A. at Carnegie Mellon University’s Tepper School of Business as a Swartz Entrepreneurial Fellow.
Previously, Dr. Hawryluk held roles in Business Development, Marketing and Product Management across multiple divisions of Thermo Fisher Scientific, Inc. In May 2022, Dr. Hawryluk was named a 2022 Emerging Pharma Leader by Pharmaceutical Executive. Dr. Hawryluk received a B.S. from the University of Notre Dame, a Ph.D. in Cell Biology and Protein Biochemistry from the University of Pittsburgh School of Medicine and an M.B.A. at Carnegie Mellon University’s Tepper School of Business as a Swartz Entrepreneurial Fellow.
